Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Accounts Payables (2021 - 2026)

Tevogen's (TVGN) quarterly Accounts Payables came in at $3.8 million in Q1 2026, down 18.57% on a YoY basis from $4.7 million in Q1 2025, and up 13.73% quarter-over-quarter from $3.3 million in Q4 2025.

Analysis

Tevogen (TVGN) Accounts Payables (2021 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Accounts Payables for 6 consecutive years, with $3.8 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Accounts Payables fell 18.57% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 18.57% YoY), and the FY2025 full-year result was $3.3 million, down 35.77% from the prior year.
  • Accounts Payables climbed to $3.8 million in Q1 2026 per TVGN's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $6.7 million in Q2 2024 and bottomed at $128999.0 in Q1 2022.
  • Historically, Accounts Payables has averaged $2.9 million across 5 years, with a median of $3.3 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Accounts Payables surged 1524.29% in 2023, then plunged 43.27% in 2025.
  • Over 5 years, Accounts Payables stood at $210454.0 in 2022, then soared by 1524.29% to $3.4 million in 2023, then soared by 52.13% to $5.2 million in 2024, then slumped by 35.77% to $3.3 million in 2025, then rose by 13.73% to $3.8 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $3.8 million, $3.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 6.54 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 11.31 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 26.21 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 77.30 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 4.98 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 13.10 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 5.30 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 50.98 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 20.61 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.80 Mn
Dec 31, 2025 3.34 Mn
Sep 30, 2025 3.31 Mn
Jun 30, 2025 4.24 Mn
Mar 31, 2025 4.66 Mn
Dec 31, 2024 5.20 Mn
Sep 30, 2024 5.84 Mn
Jun 30, 2024 6.67 Mn
Mar 31, 2024 5.21 Mn
Dec 31, 2023 3.42 Mn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 694,918.00
Mar 31, 2023 485,074.00
Dec 31, 2022 210,454.00
Sep 30, 2022 171,783.00
Jun 30, 2022 179,234.00
Mar 31, 2022 128,999.00
Dec 31, 2021 39,375.00